2024 Clinical Insights Report
Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2025 and how VytlOne clinical programs can help.
Our resources and expert guidance are crafted to help hospitals, plans, and partners lead with clarity, compassion, and impactful results.
In our second annual healthcare leadership report, 100 health system executives and pharmacy leaders…
In this edition, we’re leaning into new drug innovations, including Insmed’s new drug, Brinsupri…
In this edition, we feature new drugs to market, the clinical pipeline, and GLP-1 updates as well as a spotlight on Acute Myocardial Infarction…
A large education consortium serving more than 85 school districts and 13,000 lives saved nearly …
Learn how the PALs program helped a local county health department to support pharmacy operations …
In this edition, we explore GLP-1 compounding policy updates to groundbreaking treatments in ophthalmology…
When patients are discharged from the hospital without their prescribed medications, social determinants of health …
Discover how a community health center increased collections by 280% in just six months through …
Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2025…
Industry experts Ted Slafsky, Emily Cook, Nicole Shoquist, and William Riley break down the biggest 340B challenges…
Learn how one health system transformed their pharmacy benefit management and pharmacies to enhance care…
Don’t miss pharmacy value opportunities. Learn how one hospital created value with their strategic pharmacy services partner.
In this edition, we spotlight industry news and new to market drugs with a focus on the oncology pipeline…
Unlock new revenue opportunities and optimize pharmacy services with our first annual market report…
Watch Maxor thought leaders discuss how you can harness pharmacy data to transform your pharmacy services.
Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2025 and how VytlOne clinical programs can help.
Want to connect with VytlOne explore opportunities? Get in touch with us today.
Disease State Overview
Asthma is a long-term condition that affects the airways in your lungs. These airways can become inflamed and narrowed. This makes it harder to move air in and out of the lungs. It can affect people of all ages, although it often begins in childhood. Certain things – called triggers – can worsen asthma symptoms. When symptoms suddenly get worse, you may have an asthma attack.
There are several types of asthma, and each may require different treatment or management strategies. These include:
Experts have started to recognize the impact of inflammation in asthma. Four biological pathways of inflammation have been identified: eosinophilic, neutrophilic, mixed eosinophilic and neutrophilic, and non-inflammatory.
When asthma does not improve with long-term controller medications, it may be a sign of severe asthma. There are 2 main types of severe asthma: Type-2 inflammation and Non-Type-2 inflammation. Those patients with Type-2 severe asthma respond well to biologic medications. These treatments target specific parts of the immune system and may be obtained at your specialty pharmacy.
Related Health Symptoms and Health Concerns
Asthma can cause a variety of breathing problems. Common symptoms include:
For some people, an asthma attack may begin with a cough that doesn’t go away. Your chest may start to feel tight — some people describe it as having the air “sucked out” of them. You may also begin to wheeze or feel lightheaded.
Having and following your asthma action plan is very important. It helps to know what steps to take when symptoms start, when to use your rescue medication, and when to seek emergency care.
Call 9-1-1 right away if you are struggling to breathe, your symptoms are getting worse quickly or your rescue inhaler is not helping.
Treatment
While there is no cure for asthma, there are many treatments that can help you manage your symptoms and live a healthy, active life. Treatment usually includes monitoring your breathing, avoiding triggers, and using medications to both prevent and treat symptoms.
Most people use a combination of medications to keep their asthma under control. You may have a quick relief (rescue) medication to help stop symptoms and a long-term control medication to help prevent symptoms from happening in the first place.
The types of medications include:
Treatment Goals
The goals of treating asthma include:
Strategies to Achieve Treatment Goals
Additional resources
VytlOne Specialty Pharmacy
Rheumatology – Chronic Inflammatory Disease
Ankylosing Spondylitis (AS), Gout, Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Systemic Juvenile Idiopathic Arthritis (sJIA)
Disease State Overview
Chronic inflammatory diseases cause long-lasting inflammation in the body. This inflammation can damage healthy cells and tissues over time. Many areas of the body can be affected including, but not limited to, the digestive system, joints, skin, and respiratory system. Researchers believe that these conditions may be related to an overactive immune system, but more research is needed to understand what triggers this disruption of the immune system.
The term rheumatism is used to describe many conditions that cause inflammation in the joints, muscles, and connective tissues. It includes a wide range of diseases such as ankylosing spondylitis (AS), psoriatic arthritis (PsA), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE).
The most common symptom of rheumatologic inflammatory diseases is joint pain. Joints may also feel warm, tender, stiff, or swollen. Other symptoms may include feeling unusually tired, having low energy, occasional fevers, loss of appetite, skin rashes and vision changes. In most cases, these conditions can be cyclical. There are periods where symptoms are worse, called flares. When symptoms ease and feel better, it is called remission.
Related Symptoms and Health Concerns
If left untreated,
Treatment
Most chronic inflammatory diseases have no cure. Lifestyle changes and early treatment may help manage and prevent complications. Treatment largely depends on the severity of symptoms. Research shows that people with rheumatoid arthritis who are diagnosed early and treated aggressively do better over the long-term.
Topical creams or ointments, as well as nonsteroidal anti-inflammatory drugs (NSAIDs), may help with pain and reduce inflammation. If symptoms are widespread, more aggressive treatment may be required. Depending on the diagnosis, treatment options may include immunosuppressive therapies, such as steroids, disease-modifying antirheumatic drugs (DMARDs), or immunomodulators. Immunomodulators may help decrease the body’s hyperactive immune response in the skin, joints and other organs. Suppressing inflammation not only offers relief from common symptoms, but it also allows the tissues to heal.
Specialty medications used to treat chronic inflammatory rheumatologic conditions include, but are not limited to:
Treatment Goals
The primary goals of treating inflammatory rheumatic conditions are to:
Strategies to Achieve Treatment Goals
Sources
VytlOne Specialty Pharmacy
Atopic Dermatitis (AD), Chronic Idiopathic Urticaria, Pemphigus Vulgaris, Plaque Psoriasis
Disease State Overview
Chronic inflammatory diseases cause ongoing inflammation in the body, damaging healthy cells of the digestive system, joints, skin, respiratory system, and other organs. Researchers believe that a hyperactive immune response may play a role in these conditions. More research is required to determine what triggers this disruption of the immune system.
Atopic Dermatitis (AD), Chronic Idiopathic Urticaria, Pemphigus Vulgaris, and Plaque Psoriasis are inflammatory diagnoses that mainly affect the skin. Symptoms may include red, dry patches of skin, burning, itching, swelling, blistering, pain and/or sensitivity. In most cases, there are periods of time when the disease is worse, called flares. Then there are periods when symptoms improve, called remissions. Chronic inflammatory dermatologic conditions are not contagious.Related Symptoms and Health Concerns
If left untreated,
Treatment
Most chronic inflammatory diseases have no cure. Lifestyle changes and early treatment may help manage and prevent issues.
Treatment largely depends on the severity of symptoms, as well as other diseases present. Mild cases of skin inflammation may be treated with topical creams or ointments.
If symptoms are widespread, or joint pain is present along with skin irritation, more aggressive treatment may be required. Depending on the diagnosis, treatment options may include immunosuppressive therapies. These are steroids, methotrexate, or cyclosporine, or immunomodulators. Immunomodulators help lower the body’s hyperactive immune response in the skin and other organs. These are used for moderate to severe disease.
Suppressing inflammation offers relief from common symptoms. It also allows the skin tissue to heal.
Specialty medications used to treat chronic inflammatory dermatologic conditions include, but are not limited to:
Treatment Goals
The primary goals of treating inflammatory dermatologic conditions are to:
Strategies to Achieve Treatment Goals
Additional Resources
VytlOne Home Delivery Pharmacy